Skip to main content
. 2018 Jul 23;7(10):e1484981. doi: 10.1080/2162402X.2018.1484981

Figure 3.

Figure 3.

Maturation markers are upregulated on dendritic cells upon co-culture with EMA treated 5T33vt cells.

Murine 5T33vt myeloma cells were treated with indicated doses for 7 days with EMAs and 2 days with chemotherapy (Supplementary Figure S1I, K). Next, treated 5T33vt cells from 1 well or supernatant of treated cells was used for co-culture with primary murine DCs. One day later, DCs were analyzed for the presence of maturation markers within CD11c (+), F/40 (-), CD19 (-), CD3 (-) 7AAD (-) events. LPS was used a positive control for DC maturation.Left: Double positive for CD80/MHC-I. Middle: Double positive for CD40/MHC-I.Right: Double positive for CD86/MHC-II. Bars and error bars represent mean and standard deviation. Statistics were done using One-Way-Anova. *, **, *** indicates p < 0.05, p < 0.001, p < 0.0001, respectively. (DC = dendritic cell, cnt = control, DAC = decitabine, Quis = Quisinostat, Bz = Bortezomib, Mel = Melphalan, Mtx = Mitoxanthrone, LPS = lipopolysaccharide).